🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 49721T101 (prev. 30233M503 )
- Market Cap
- Micro Cap
- IPO
- 7/29/2015 · $8.50/share
- Previous Symbol
- EYEG (changed 11/5/2021)
- Previous Name
- Eyegate Pharmaceuticals, Inc.
Business: Kiora Pharmaceuticals, Inc. is a clinical-stage biotechnology company developing and commercializing products for treating ophthalmic diseases. KIO-301 is a molecular photoswitch that has the potential to restore light perception in patients with inherited and/or age-related retinal degeneration.
Company Contact
- CEO
- Brian M. Strem
- CFO
- Melissa Tosca
- Headquarters
- 332 Encinitas Blvd. Suite 102, Encinitas, CA 92024
- Phone
- 858-224-9600
- Investor Relations
- Francina Agosti · 617-546-0742 · fagosti@reportablenews.com